Arterez. Inc. is a Michigan biosciences group focused on the discovery and development of therapeutics and diagnostics against chronic vascular diseases by targeting upstream disease etiology.
Led by Dr. Joe Tunac, a successful medical scientist and drug developer of 40 years, the company has developed a drug capable of preventing and reversing arterial plaques that has proven nontoxic as well as diagnostic panels to detect plaque levels in the blood stream.
Join Spotlight Family Office Group for a virtual event to learn from Dr. Tunac who is a medical scientist specializing in the discovery and development of drugs and has 40 years of drug development experience.